How has been the historical performance of Brooks Lab.?

Answer:The historical performance of Brooks Lab shows a fluctuating trend in key financial metrics over the past five years.

Breakdown:
Brooks Lab's net sales increased from 63.20 Cr in March 2023 to 82.56 Cr in March 2025, reflecting a recovery from a dip in sales in March 2022 when they were at 91.08 Cr. The total operating income followed a similar pattern, rising to 82.56 Cr in March 2025 from 63.20 Cr in March 2023. However, the company faced challenges with its total expenditure, which decreased from 105.44 Cr in March 2022 to 77.62 Cr in March 2025. Operating profit showed significant improvement, moving from a loss of 26.42 Cr in March 2023 to a profit of 4.94 Cr in March 2025. Despite these gains, the net profit remained negative, improving from -27.74 Cr in March 2023 to -9.97 Cr in March 2025. The earnings per share also reflected this trend, improving from -8.46 in March 2023 to -3.8 in March 2025. The company's total assets decreased from 194.56 Cr in March 2022 to 90.45 Cr in March 2024, while total liabilities also declined from 162.08 Cr in March 2021 to 90.45 Cr in March 2024. Cash flow from operating activities remained negative, indicating ongoing challenges in generating cash from core operations. Overall, Brooks Lab's financial performance shows signs of recovery, particularly in sales and operating profit, but still faces hurdles in achieving profitability.